N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer

NCT01138137 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No funding was available for the cost of the IV N-acetylcysteine (NAC).

Conditions

Ovarian Carcinoma, Stage 3 or 4
Epithelial Ovarian Carcinoma
Primary Peritoneal Carcinoma

Interventions

DRUG: Paclitaxel
DRUG: N-acetylcysteine
DRUG: Cisplatin

Sponsor

OHSU Knight Cancer Institute